Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Prosanus LLC is currently overseeing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner and 1 distinct art unit. The concentration of 1 pending office action within a single technical domain suggests a specific focus for the company's current intellectual property efforts.
The busiest examiner for this portfolio is ABRAHAM, AMJAD A, who is handling 1 pending office action. This 1 busiest examiner pending case constitutes the full extent of the company's current workload at the patent office. Because the portfolio involves 1 distinct art unit, the examination is occurring within a single administrative group. The data indicates that 1 distinct examiner is responsible for the active matter, creating a direct line of communication for this file. This focused activity in Biotechnology & Pharmaceuticals provides a clear view of the company's immediate prosecution priorities. Practitioners can expect a highly specialized review process given the alignment of the examiner and the 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABRAHAM, AMJAD A | 1 | 31.7% | +35.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682255 | Oral Rinse Formulations Having Essential Oils | ABRAHAM, AMJAD A | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18682255 | Oral Rinse Formulations Having Essential Oils | ABRAHAM, AMJAD A | 1663 | §103 | Non-Final OA | — | Pending | Feb 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial